Deferasirox

Actavis Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 31, 2021
Approval ID: ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95
Products: 3 registered
Version: 26

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005

Quick Stats

Total Products3

Labelers2

Label Sections37

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.